Quarry LP Cytokinetics Inc Transaction History
Quarry LP
- $712 Billion
- Q4 2024
A detailed history of Quarry LP transactions in Cytokinetics Inc stock. As of the latest transaction made, Quarry LP holds 800 shares of CYTK stock, worth $34,272. This represents 0.01% of its overall portfolio holdings.
Number of Shares
800
Previous 3,000
73.33%
Holding current value
$34,272
Previous $158 Million
76.24%
% of portfolio
0.01%
Previous 0.04%
Shares
4 transactions
Others Institutions Holding CYTK
# of Institutions
406Shares Held
115MCall Options Held
3.46MPut Options Held
1.86M-
Black Rock Inc. New York, NY14.7MShares$629 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$510 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.8MShares$461 Million0.31% of portfolio
-
State Street Corp Boston, MA6.17MShares$264 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA2.84MShares$122 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.03B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...